The provided source material details specific programmes and discount mechanisms available to patients seeking access to Addyi, a prescription medication for hypoactive sexual desire disorder in premenopausal women. The information focuses exclusively on United States-based access, cost reduction strategies, and pharmacy fulfilment options. It does not contain information regarding free samples, mail-in sample programmes, or promotional offers available to consumers in the United Kingdom.
According to the source data, Addyi is accessible through various channels designed to reduce the financial burden on patients. Two primary avenues for acquisition and cost reduction are highlighted: a specialty pharmacy partner offering direct delivery and a nationwide availability through a prescription discount platform.
Pharmacy Fulfilment and Delivery Options
One specific channel for obtaining Addyi is through PhilRX, identified as a specialty pharmacy partner. The sources indicate that PhilRX offers the medication at a "guaranteed lowest price." A key benefit of this service, as stated in the source material, is the inclusion of free shipping directly to the patient's door. This option appears to be designed for patients who prefer the convenience of home delivery.
For patients who prefer to utilise a local pharmacy, the sources mention that Addyi is available at over 70,000 pharmacies nationwide. This availability is facilitated through GoodRX. The data suggests that patients have the flexibility to choose between the direct-to-door service provided by PhilRX or the local collection option available via GoodRX.
Cost Reduction and Discount Programmes
The source material places significant emphasis on methods to reduce prescription costs. Several discount mechanisms are described, including coupons, discount cards, and copay assistance programmes.
General Discount Coupons and Cards
The documentation states that all patients are eligible to receive a discount by using a free Addyi coupon, which can save up to 80% on prescription costs when used at a local pharmacy. Additionally, a "Free Prescription Discount Card" is detailed. Key features of this card, as explicitly listed in the sources, include:
- No registration required.
- Eligibility for everyone.
- Potential discounts of up to 80%.
- Usability regardless of insurance status (can be used by those with or without insurance).
- No expiration date.
- Immediate readiness (no activation required).
These general discount tools are presented as accessible options for a broad range of patients looking to lower their out-of-pocket expenses.
Copay Assistance and Savings Cards
For patients with specific insurance coverage, the sources detail a "Addyi Savings Card." This programme is targeted at "eligible commercially insured patients." According to the data, patients using this card may pay as little as $20 per monthly prescription. The sources provide a contact number (855-280-0581) for patients seeking additional information about this specific savings programme.
Patient Assistance Programmes (PAPs)
The source material also references Patient Assistance Programmes (PAPs). These programmes are described as being usually sponsored by pharmaceutical companies. Their purpose is to provide free or discounted medicines and copay programmes to individuals who meet specific guidelines. The target demographic for PAPs, according to the sources, includes low-income, uninsured, or under-insured people.
Pricing Variability and Eligibility
The documentation notes that the cost of Addyi may vary based on the pharmacy from which the prescription is filled. This suggests that patients should compare prices across different pharmacies or utilise the mentioned discount options to secure the best price.
Regarding eligibility for the various programmes:
- General Coupons/Cards: The sources state that "all patients are eligible" for the free discount drug coupon and that "everyone is eligible" for the prescription discount card.
- Copay Savings Card: This is restricted to "eligible commercially insured patients."
- Patient Assistance Programmes: These are restricted to those meeting specific income and insurance status guidelines.
Important Medical and Regulatory Information
The source material includes a specific warning regarding side effects. Patients are advised to call their doctor for medical advice about side effects and may report side effects to the FDA at 1-800-FDA-1088.
Furthermore, Source [4] indicates that the site is intended for residents of the United States. It references the "Full Prescribing Information and Medication Guide, including Boxed Warning for severe low blood pressure and fainting," which can be found at addyi.com/pi. The trademark owner is identified as Sprout Pharmaceuticals, Inc.
Conclusion
The provided source material offers a detailed overview of how patients in the United States can access Addyi and reduce the associated costs. The primary methods involve using a specialty pharmacy partner for direct delivery or utilising GoodRX for local pharmacy access. Significant cost reductions are available through various discount cards, coupons, and a specific savings card for commercially insured patients, potentially lowering the monthly cost to $20. Patient Assistance Programmes are also available for those meeting specific low-income and insurance criteria. The information does not support the existence of free samples or mail-in sample programmes for this product.